Table 6.
Biomarkers | Control male | Control Female | Treated male rats | Treated female rats |
---|---|---|---|---|
HB (g/L) | 11.20 ± 1.23a | 11.00 ± 1.980 a | 15.40 ± 1.20 b | 14. 99 ± 1.00b |
RBCs (million cells/ul) | 6.00 ± 0.91a | 5.50 ± 0.60 a | 6.90 ± 0.68 a | 5.80 ± 0.56 a |
PCV (%) | 33.50 ± 4.10a | 33.00 ± 3.50 a | 34.00 ± 3.90a | 33.00 ± 3.00a |
WBCs(× 109/L) | 7. 600 ± 66.50a | 7.400 ± 70.50 a | 7.600 ± 65.00 a | 7.00 ± 54.00 a |
Neutrophils (×109/L) | 21.00 ± 1.20a | 19.95 ± 1.70 a | 19.00 ± 1.10a | 19.45 ± 1.50a |
Eosinophil (x100 cells /uL). |
1.60 ± 0.07a | 1.60 ± 0.05a | 1.66 ± 0.05a | 1.69 ± 0.07a |
Lymphocyte(109/L) | 72.00 ± 5.26a | 73.00 ± 5.80 a | 74.00 ± 4.90a | 74.00 ± 7.10a |
Monocyte(109/L | 1.55 ± 0.06a | 1.53 ± 0.05 a | 1.50 ± 0.11a | 1.53 ± 0.10a |
Platelets (x 109/L) | 740.00 ± 50.00a | 770.00 ± 65.00 a | 800.00 ± 60.00 a | 780.00 ± 45.00 a |
Data are Means ± SD of 15 mice in treated group. Statistical analysis is carried out using Co-state and SPSS computer programs (version 7), where unshared letter is significant at P ≤ 0.05.